Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for clinical use only 15 years ago. Since then, 33 more kinase inhibitor drugs have received regulatory approval for the treatment...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017
|
| Online Access: | http://eprints.nottingham.ac.uk/37903/ http://eprints.nottingham.ac.uk/37903/ http://eprints.nottingham.ac.uk/37903/ http://eprints.nottingham.ac.uk/37903/1/Fischer_PM_Med_Res_Rev_2016_ePrint.pdf |